glicentin has been researched along with Adolescent Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, BK; Bergsten, P; Cerenius, SY; Chowdhury, A; Ciba, I; Forslund, A; Gjessing, ES; Gomahr, J; Heu, V; Kristinsson, H; Manell, H; Mörwald, K; Stenlid, R; Weghuber, D; Wen, Q | 1 |
| Bergsten, P; Cen, J; Ciba, I; Forslund, A; Kristinsson, H; Manell, H; Manukyan, L; Staaf, J; Stenlid, R | 1 |
2 other study(ies) available for glicentin and Adolescent Obesity
| Article | Year |
|---|---|
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.
Topics: Adolescent; Child; Exenatide; Glicentin; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycemic Control; Humans; Insulin; Pediatric Obesity; Proinsulin | 2023 |
Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
Topics: Adolescent; Blood Glucose; Case-Control Studies; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glicentin; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Glucose Tolerance Test; Humans; Male; Pediatric Obesity; Sweden | 2016 |